Common Contracts
7 similar Amendment Agreement contracts by Immunomedics Inc
AMENDMENT AGREEMENTAmendment Agreement • September 24th, 2020 • Immunomedics Inc • In vitro & in vivo diagnostic substances • Delaware
AMENDMENT AGREEMENT (this “Agreement”), by and between Immunomedics, Inc. (the “Company”), a Delaware corporation and John Stubenrauch (the “Executive”), dated as of the 12th day of September, 2020.
AMENDMENT AGREEMENTAmendment Agreement • September 24th, 2020 • Immunomedics Inc • In vitro & in vivo diagnostic substances • Delaware
AMENDMENT AGREEMENT (this “Agreement”), by and between Immunomedics, Inc. (the “Company”), a Delaware corporation and Bryan Ball (the “Executive”), dated as of the 12th day of September, 2020.
AMENDMENT AGREEMENTAmendment Agreement • September 24th, 2020 • Immunomedics Inc • In vitro & in vivo diagnostic substances • Delaware
AMENDMENT AGREEMENT (this “Agreement”), by and between Immunomedics, Inc. (the “Company”), a Delaware corporation and Kurt Andrews (the “Executive”), dated as of the 12th day of September, 2020.
AMENDMENT AGREEMENTAmendment Agreement • September 24th, 2020 • Immunomedics Inc • In vitro & in vivo diagnostic substances • Delaware
AMENDMENT AGREEMENT (this “Agreement”), by and between Immunomedics, Inc. (the “Company”), a Delaware corporation and Brendan Delaney (the “Executive”), dated as of the 12th day of September, 2020.
AMENDMENT AGREEMENTAmendment Agreement • September 24th, 2020 • Immunomedics Inc • In vitro & in vivo diagnostic substances • Delaware
AMENDMENT AGREEMENT (this “Agreement”), by and between Immunomedics, Inc. (the “Company”), a Delaware corporation and Loretta Itri (the “Executive”), dated as of the 12th day of September, 2020.
AMENDMENT AGREEMENTAmendment Agreement • September 24th, 2020 • Immunomedics Inc • In vitro & in vivo diagnostic substances • Delaware
AMENDMENT AGREEMENT (this “Agreement”), by and between Immunomedics, Inc. (the “Company”), a Delaware corporation and Jared Freedberg (the “Executive”), dated as of the 12th day of September, 2020.
AMENDMENT AGREEMENTAmendment Agreement • September 24th, 2020 • Immunomedics Inc • In vitro & in vivo diagnostic substances • Delaware
AMENDMENT AGREEMENT (this “Agreement”), by and between Immunomedics, Inc. (the “Company”), a Delaware corporation and Usama Malik (the “Executive”), dated as of the 12th day of September, 2020.
